These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7717926)

  • 21. Treating lipid disorders.
    Manninen V; Mälkönen M; Tuomilehto J
    Am Heart J; 1979 May; 97(5):674-6. PubMed ID: 219673
    [No Abstract]   [Full Text] [Related]  

  • 22. The clofibrate saga: a retrospective commentary.
    Oliver M
    Br J Clin Pharmacol; 2012 Dec; 74(6):907-10. PubMed ID: 22486628
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hyperlipidemia in the elderly].
    Kawano M
    Nihon Rinsho; 2002 May; 60(5):1017-23. PubMed ID: 12029980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Enduracin--a nicotinic acid preparation in the treatment of hypercholesterolemia].
    Kardiologiia; 1993; 33(11):67-80. PubMed ID: 8145429
    [No Abstract]   [Full Text] [Related]  

  • 25. Intensive drug therapy of hypercholesterolemia.
    Witztum JL
    Am Heart J; 1987 Feb; 113(2 Pt 2):603-9. PubMed ID: 3544777
    [No Abstract]   [Full Text] [Related]  

  • 26. Primary coronary risk factors and secondary prevention of coronary heart disease.
    Kornitzer M
    Adv Cardiol; 1982; 31():162-7. PubMed ID: 6758504
    [No Abstract]   [Full Text] [Related]  

  • 27. Update on the treatment of hypercholesterolemia, with a focus on HMG-CoA reductase inhibitors and combination regimens.
    Ginsberg HN
    Clin Cardiol; 1995 Jun; 18(6):307-15. PubMed ID: 7664504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.
    Schrott HG; Bittner V; Vittinghoff E; Herrington DM; Hulley S
    JAMA; 1997 Apr 23-30; 277(16):1281-6. PubMed ID: 9109465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspectives in the treatment of dyslipidemias in the prevention of coronary heart disease.
    Borgia MC; Medici F
    Angiology; 1998 May; 49(5):339-48. PubMed ID: 9591525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term safety of statin-fibrate combination treatment in the management of hypercholesterolaemia in patients with coronary artery disease.
    Feher MD; Foxton J; Banks D; Lant AF; Wray R
    Br Heart J; 1995 Jul; 74(1):14-7. PubMed ID: 7662446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinogenicity of lipid-lowering drugs.
    JAMA; 1996 May; 275(19):1481-2. PubMed ID: 8622220
    [No Abstract]   [Full Text] [Related]  

  • 32. [Lipid lowering therapy in primary prevention of coronary heart disease--introduction].
    Schuff-Werner P
    Z Kardiol; 1998; 87 Suppl 2():203-4. PubMed ID: 9827483
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipid-lowering therapy for the primary prevention of coronary heart disease.
    Gotto AM
    J Am Coll Cardiol; 1999 Jun; 33(7):2078-82. PubMed ID: 10362217
    [No Abstract]   [Full Text] [Related]  

  • 34. Niacin: its value in raising HDL cholesterol is being questioned.
    Heart Advis; 2011 Oct; 14(10):7. PubMed ID: 23019714
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmaco-economics of hypolipidemic agents: analysis of factors influencing the cost-effectiveness relation].
    Scheen AJ
    Rev Med Liege; 1998 May; 53(5):270-5. PubMed ID: 9689881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reassessment of National Cholesterol Education Program Adult Treatment Panel-III guidelines: one year later.
    Ansell BJ; Waters DD;
    Am J Cardiol; 2002 Sep; 90(5):524-5. PubMed ID: 12208415
    [No Abstract]   [Full Text] [Related]  

  • 37. A Meta-Analysis of Cardiovascular Outcomes in Patients With Hypercholesterolemia Treated With Bempedoic Acid.
    Asbeutah AAA; Asbeutah SA; Abu-Assi MA
    Am J Cardiol; 2020 Oct; 132():166-168. PubMed ID: 32713651
    [No Abstract]   [Full Text] [Related]  

  • 38. Needed: pragmatic clinical trials for statin-intolerant patients.
    Maningat P; Breslow JL
    N Engl J Med; 2011 Dec; 365(24):2250-1. PubMed ID: 22085320
    [No Abstract]   [Full Text] [Related]  

  • 39. Does lowering cholesterol cause cancer?
    Dalen JE; Dalton WS
    JAMA; 1996 Jan; 275(1):67-9. PubMed ID: 8531290
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comment from tHE cardiologic-angiologic viewpoint].
    Rosemann A
    Praxis (Bern 1994); 2011 Jul; 100(14):857-8. PubMed ID: 21732298
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.